Nomura Holdings NMR
Valuation
Multiples measured against the stock's own five-year history
Below its usual level · 25th percentile, 5-year average 7.0x
#671 of 2996 stocks by PE (1 = cheapest)
Near the top of its 5-year range · 85th percentile, 5-year average 0.7x
#1707 of 5338 stocks by PB (1 = cheapest)
Above its usual level · 67th percentile, 5-year average 1.5x
#2386 of 5161 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 1.05 | – | 0.74 | 85% (pricier than usual) | #1707 of 5338 (1 = cheapest) |
| PE | 9.88 | 8.49 | 6.98 | 25% (cheaper than usual) | #671 of 2996 (1 = cheapest) |
| PS | 1.63 | 1.58 | 1.48 | 67% (pricier than usual) | #2386 of 5161 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on NMR.
Sign in to join the discussion.